2021 annual financial data

Dianthus Therapeutics 2021 Operating cash flow margin

Dianthus Therapeutics 2021 operating cash flow margin with verified reported va…

Direct answer

Operating cash flow margin was -4,033.27%.

Operating income was -13,086,000 USD and net income was -13,109,000 USD.
Operating cash flow was -59,531,000 USD.

Get free Dianthus Therapeutics email updates.

Bullstory sends one daily email when new analysis or important company news is available.

Verified data

Revenue
1,476,000 USD
Operating income
-13,086,000 USD
Net income
-13,109,000 USD
Operating cash flow
-59,531,000 USD